Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Vrelysin by Intralytix for Vancomycin-Resistant Enterococcus faecium Infections: Likelihood of Approval
Vrelysin is under clinical development by Intralytix and currently in Phase II for Vancomycin-Resistant Enterococcus faecium Infections. According to GlobalData,...